June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Effectiveness of an artificial-intelligence based single-exam retinopathy of prematurity prediction model in three Asian populations
Author Affiliations & Notes
  • J. Peter Campbell
    Oregon Health & Science University, Portland, Oregon, United States
  • Aaron S Coyner
    Oregon Health & Science University, Portland, Oregon, United States
  • Minn Oh
    Oregon Health & Science University, Portland, Oregon, United States
  • Parag Shah
    Aravind Eye Care System, Coimbatore, Tamil Nadu, India
  • Praveer Singh
    Massachusetts General Hospital, Boston, Massachusetts, United States
  • Susan R Ostmo
    Oregon Health & Science University, Portland, Oregon, United States
  • Nita Valikodath
    Duke University School of Medicine, Durham, North Carolina, United States
  • Emily Cole
    University of Illinois at Chicago, Chicago, Illinois, United States
  • Tala Al-Khaled
    University of Illinois at Chicago, Chicago, Illinois, United States
  • Sanyam Bajimaya
    Tilganga Institute of Ophthalmology, Kathmandu, Nepal
  • Sagun KC
    Helen Keller International, New York, New York, United States
  • Tsengelmaa Chuluunbat
    National Center for Maternal and Child Health of Mongolia, Ulaanbaatar, Ulaanbaatar, Mongolia
  • Bayalag Munkhuu
    National Center for Maternal and Child Health of Mongolia, Ulaanbaatar, Ulaanbaatar, Mongolia
  • R.V. Paul Chan
    University of Illinois at Chicago, Chicago, Illinois, United States
  • Michael F Chiang
    National Eye Institute, Bethesda, Maryland, United States
  • Jayashree Kalpathy-Cramer
    Massachusetts General Hospital, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   J. Peter Campbell Boston AI, Code C (Consultant/Contractor), Siloam Vision, Code O (Owner); Aaron Coyner None; Minn Oh None; Parag Shah None; Praveer Singh None; Susan Ostmo None; Nita Valikodath None; Emily Cole None; Tala Al-Khaled None; Sanyam Bajimaya None; Sagun KC None; Tsengelmaa Chuluunbat None; Bayalag Munkhuu None; R.V. Paul Chan Siloam Vision, Code O (Owner); Michael Chiang None; Jayashree Kalpathy-Cramer None
  • Footnotes
    Support  This work was supported by grants R01 EY19474, R01 EY031331, R21 EY031883, and P30 EY10572 from the National Institutes of Health (Bethesda, MD), and by unrestricted departmental funding and a Career Development Award (JPC) from Research to Prevent Blindness (New York, NY), and with support from the US Agency for International Development (USAID) and the Seva Foundation.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3129. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Peter Campbell, Aaron S Coyner, Minn Oh, Parag Shah, Praveer Singh, Susan R Ostmo, Nita Valikodath, Emily Cole, Tala Al-Khaled, Sanyam Bajimaya, Sagun KC, Tsengelmaa Chuluunbat, Bayalag Munkhuu, R.V. Paul Chan, Michael F Chiang, Jayashree Kalpathy-Cramer; Effectiveness of an artificial-intelligence based single-exam retinopathy of prematurity prediction model in three Asian populations. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3129.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Previous work has demonstrated that an artificial-intelligence (AI) based retinopathy of prematurity (ROP) risk model could provide both early prediction of treatment-requiring (TR) ROP and reduce the overall number of examinations in a US population. However, significant demographic differences exist between US and low and middle income countries (LMIC), which may limit translation of risk models based on demographics to other populations. In this work, we evaluate whether a modified AI-based risk model could perform with high sensitivity despite demographic differences in 3 LMICs.

Methods : Retinal fundus images were collected from 2351 subjects as part of an Indian ROP telemedicine screening program. A VSS was derived from the first exam after 30 weeks postmenstrual age. Using five-fold cross-validation, logistic regression models were trained and validated on 2 variables (gestational age at birth and VSS at first exam) for the eventual outcome of TR-ROP. Sensitivity, specificity, and respective 95% confidence intervals (CIs) were evaluated on test datasets acquired from Indian (n = 762 subjects, 27 TR-ROP), Nepalese (n = 330 subjects, 3 TR-ROP), and Mongolian babies (n = 319 subjects, 53 TR-ROP). All 3 test sets were consecutive population-based cohorts imaged as part of ROP telescreening programs.

Results : For the Indian, Nepalese, and Mongolian test datasets, the model had sensitivity [95% CI] equal to 100.0% [87.2%, 100.0%], 100.0% [29.2%, 100.0%], and 100.0% [93.3%, 100.0%], respectively. Specificity was 63.3% [59.7%, 66.8%], 77.1% [72.27%, 81.6%], and 45.8% [39.7%, 52.1%]. The mean ± standard deviation weeks subjects were identified prior to TR-ROP diagnosis was 2.1 ± 2.5, 0.7 ± 1.2, and 4.7 ± 5.1 weeks. Post-hoc analysis of the Indian dataset determined that, if those who screened negative were to never be screened again, the total number of examinations could be reduced by 45.0%.

Conclusions : We found 100% sensitivity and moderate specificity of a modified AI-based ROP risk model in 3 LMIC populations. There are two potential advantages to implementation of this risk model in ROP telescreening programs: (1) high-risk infants could be identified well before TR-ROP diagnosis, potentially reducing the risk of late treatment, and (2) the number of exams required to effectively screen a population could be significantly reduced.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×